Case report: Long-term outcome post-heart transplantation in a woman with Fabry's disease

Journal of Inherited Metabolic Disease

Volumn 33, Issue SUPPL. 3, 2010, Pages

  Verocai, Flavia ^a,b,d   Clarke, Joe Thomas ^a,c   Iwanochko, Robert M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

^d TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOMYOPATHY; CASE REPORT; FABRY DISEASE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; TIME; TREATMENT OUTCOME; CARDIOMYOPATHIES; COMPLICATION;

CARDIOMYOPATHIES; FABRY DISEASE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84897954706     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9194-3     Document Type: Article

References (17)

1. Pierre-Louis B, Kumar A, Frishman WH (2009) Fabry disease: cardiac manifestations and therapeutic options. Cardiol Rev 17:31-35
2. Linhart A, Elliott PM (2007) The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart 93(4):528-535
3. Clarke JTR (2007) Narrative review: Fabry disease. Ann Intern Med 146:425-433
4. Chimenti C, Pieroni M, Morgante E, Antuzzi D, Russo A, Russo MA, Maseri A, Frustaci A (2004) Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy. Circulation 110:1047-1053
5. Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, Yoshida H, Horinouchi M, Tabata K, Yonezawa S, Yoshimitsu M, Higuchi K, Nakao S, Anan R, Minagoe S, Tei C (2008) Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol 51:50-59
6. Cecchi F, Frullini A, Olivotto I, Castelli G, Ciaccheri M, Martinelli F, Torricelli F, Borsini W, Garbini F (2007) Hypertrophic cardiomyopathy in Anderson-Fabry disease. Clin Ther 29 (Suppl C):S93-S94
7. Wilcox WR, Oliveira JP, Hopkin RJ, Ortiz A, Banikazemi M, Feldt-Rasmussen U, Sims K, Waldek S, Pastores GM, Lee P, Eng CM, Marodi L, Stanford KE, Breunig F, Wanner C, Warnock DG, Lemay RM, Germain DP (2008) Fabry Registry. Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry. Mol Genet and Metabol 93(2):112-128
8. Mehra MR, Kobashigawa J, Starling R, Russell S, Uber PA, Parameshwar J, Mohacsi P, Augustine S, Aaronson K, Barr M (2006) Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates-2006. J Heart Lung Transplant 25(9):1024-1042
9. Cantor WJ, Daly P, Iwanochko M, Clarke JTR, Cusimano RJ, Butany J (1998) Cadiac transplantation for Fabry's disease. Can J Cardiol 14(1):81-84
10. Kleinert K, Kotanko P, Spada M, Pagliardini S, Paschke E, Paul K, Voigtlander T, Wallner M, Kramar R, Stummvoll HK, Schwarz C, Horn S, Holzer H, Fodinger M, Sunder-Plassmann G (2009) Anderson-Fabry disease: a case-finding study among male kidney transplant recipients in Austria. Transpl Int 22(3):287-292
11. Cybulla M, Walter KN, Schwarting A, Divito R, Feriozzi S, Sunder-Plassmann G, European FOS Investigators Group (2009) Kidney transplantation in patients with Fabry disease. Transpl Int 22 (4):475-481
12. Karras A, De Lentdecker P, Delahousse M, Debauchez M, Tricot L, Pastural M, Bruneval P, Zemoura L, Van Huyen DJ, Lidove O (2008) Combined heart and kidney transplantation in a patient with Fabry disease in the enzyme replacement therapy era. Am J Transplant 8:1345-1348
13. Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Mehta AB (2008) Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Heart 94:153-158
14. Breunig F, Weidemann F, Strotmann J, Knoll A, Wanner C (2006) Clinical benefit of enzyme replacement therapy in Fabry disease. Kidney Int 69:1216-1221
15. Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Störk S, Voelker W, Ertl G, Wanner C, Strotmann J (2009) Long-term rffects of rnzyme replacement therapy on Fabry cardiomyopathy evidence for a better outcome with early rreatment. Circulation 119:524-529
16. Mehta A, BeckM, Elliott P, Giugliani R, Linhart A, Sunder-Plassmann G, Schiffmann R, Barbey F, Ries M, Clarke JT (2009) Fabry Outcome Survey investigators. Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data. Lancet 374(9706):1986-1996
17. Weidemann F, Linhart A, Monserrat L, Strotmann J (2010) Cardiac challenges in patients with Fabry disease. Int J Cardiol 141(1):3-10